Boston Business Journal March 28, 2017 4:40 pm Boston Business Journal Report: Drug Approved Amid Questions Biotech reporter Max Stendahl joins necn to discuss his story, “FDA approves SAnofi Genzyme drug amids question over patent, cost.” US & World Videos 1:32 Amber Alert for 2 NH girls canceled, father in custody 2:53 Latest on Lewiston, Maine shootings 2:01 Local researchers looking to turn plastic into fuel 1:45 Gov. Healey to sign bottle ban order for state agencies 2:41 Leominster students return to school after floods
